Altered Expression and New Mutations in DNA Mismatch Repair Genes MLH1 and MSH2 in Melanoma Brain Metastases

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 981-986

  Korabiowska, Monika ^a   König, Fatima ^a   Verheggen, Raphaela ^a   Schlott, Thilo ^a   Cordon Cardo, Carlos ^b   Romeike, Bernd ^c   Brinck, Ulrich ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Brain tumors; DNA repair; Immunohistochemistry; Melanoma brain metastases; Mutations

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CLINICAL ARTICLE; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BASE PAIR MISMATCH; BRAIN NEOPLASMS; CARRIER PROTEINS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENOMIC INSTABILITY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 2442426372     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brega K, Robinson WA, Winston K and Wittenberg W: Surgical treatment of brain metastases in malignant melanoma. Cancer 66: 2105-2110, 1990.
2. Posner JB: Management of brain metastases. Rev Neurol 148: 477-487, 1988.
3. Saphner TJ, Gallion HH, van Nagell JR, Kryscio R and Patchell RA: Neurologic complications of cervical cancer, a review of 2261 cases. Cancer 64: 1147-1151, 1989.
4. Au KG, Cabera M, Miller JH and Modrich P: Escherichia coli mutY gene product is required for specific A-G-C-G mismatch correction. Proc Natl Acad Sci USA 85: 9163-9166, 1988.
5. Su SS and Modrich P: Escherichia coli mutS-encoded protein binds to mismatched DNA base pairs. Proc Natl Acad Sci USA 83: 5057-5061, 1986.
6. Welsh KM, Lu AL, Clark S and Modrich P: Isolation and characterization of the Escherichia coli mutH gene product. J Biol Chem 262: 15624-15629, 1987.
7. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J and Hamilton SR: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-815, 1993.
8. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M and Jarvinen HJ: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430-433, 1995.
9. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M and Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colorectal cancer. Cell 75: 1027-1038, 1993.
10. Vogelstein B, Fearon ER and Hamilton SR:Genetic alterations during colorectal tumor development. New Engl J Med 319: 525-532, 1988.
11. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J and Lindbloom A: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colorectal cancer. Nature 368: 258-261, 1994.
12. Hahn SA and Schmiegel WH: Mutationen der Gene hMSH2 und hMLH1 sind für 90% der hereditären kolorektalen Karzinome verantwortlich. Z Gastroenterol 33: 135-137, 1995.
13. Papadopoulos N and Lindblom A: Molecular basis of HNPCC: Mutations of MMR genes. Hum Mut 10: 89-99, 1997.
14. Cunningham JM, Shan A, Wick MJ, Bostwick DG and Thibodeau SN: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56: 4475-4482, 1996.
15. Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994.
16. Mutter GL, Boynton KA, Faquin WC, Ruiz RE and Jovanovic AS: Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancers. Cancer Res 56: 4483-4486, 1996.
17. Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021-4026, 1996.
18. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ and Kern SE: Allelotype of pancreatic adenocarcinoma. Cancer Res 54: 2761-2764, 1995.
19. Korabiowska M, Dengler H, Kellner S, Stachura J and Schauer A: Decreased expression of MLH1, MSH2, PMS1 and PMS2 in pigmented lesions indicates accumulation of failed DNA repair along with malignant transformation and tumor progression. Oncol Rep 4: 653-655, 1997.
20. Korabiowska M, Brinck U, Dengler H, Stachura J, Schauer A and Droese M: Analysis of the DNA mismatch repair proteins in malignant melanomas. Anticancer Res 20: 4499-4506, 2000.
21. Korabiowska M, Ruschenburg I, Schlott T, Kubitz A, Brinck U and Droese M: Relation between DNA-ploidy status and the expression of DNA-mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastases. Diagn Cytopathol 24: 157-162, 2000.
22. Korabiowska M, Viehöver M, Schlott T, Berger H, Droese M and Brinck U: Relationship between DNA-ploidy related parameters and the deletions in mismatch repair genes MLH1 and MSH2 in lentigo maligna and malignant melanomas. Arch Dermatol Res 293: 219-225, 2001.
23. Gomori E, Fulop Z, Meszaros I, Doczi T and Matolcsy A: Microsatellite analysis of primary and recurrent glial tumors suggests different modalities of clonal evolution of tumor cells. J Neuropathol Exp Neurol 61: 396-402, 2002.
24. Leung SY, Chan TL, Chung LP, Chan AS, Fan YW, Hung KN, Kwong WK, Ho JW and Yuen ST: Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. Am J Pathol 153: 1181-1188, 1998.
25. Lee SE, Johnson SP, Hale LP, Li J, Bullock N, Fuchs H, Friedman A, McLendon R, Bigner DD, Modrich P and Friedman HS: Analysis of DNA mismatch repair proteins in human medulloblastoma. Clin Cancer Res 4: 1415-1419, 1998.
26. Alvino E, Fernandez E and Pallini R: Microsatellite instability in primary brain tumors. Neurol Res 22: 571-575, 2000.
27. Zhu J, Guo SZ, Beggs AH, Maruyama T, Santarius T, Dashner K, Olsen N, Wu JK and Black P: Microsatellite instability analysis of primary human brain tumors. Oncogene 12: 1417-1423, 1996.
28. Hussein MR, Roggero E, Sudilovsky EC, Tuthill RJ, Wood GS and Sudilovsky O: Alterations of mismatch repair protein expression in benign melanocytic naevi, melanocytic dysplastic naevi, and cutaneous malignant melanomas. Am J Dermatopathol 23: 308-314, 2001.
29. Rass K, Gutwein P, Welter C, Meineke V, Tilgen V and Reichrath J: DNA mismatch repair enzyme hMSH2 in malignant melanoma increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines. Histochem J 33: 459-467, 2001.
30. Staibano S, Lo Muzio L, Pannone G, Somma P, Farronato G, Franco-Bambini F, Serpico R and DeRosa G: P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region. Int J Oncol 19: 551-559, 2001.
31. Hussein MR, Sun M, Tuthill RJ, Roggero E, Monti JA, Sudilovsky E, Wood GS and Sudilovsky O: Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi but not in benign nevi. J Cutan Pathol 28: 343-350, 2001.
32. Kroiss MM, Vogt TM, Schlegel J, Landthaler M and Stolz W: Microsatellite instability in malignant melanomas. Acta Derm Venerol 81: 242-245, 2001.
33. Quinn AG, Healy E, Rehman I, Sikkink S and Rees JL: Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Dermatol 104: 309-312, 1995.
34. Richetta A, Ottini L, Fralchetti M, Innocenzi D, Bottoni U, Faiola R, Mariani-Costantini R and Calvieri S: Instability at sequence repeats in melanocytic tumors. Melanoma Res 11: 283-289, 2001.
35. Talwalkar VR, Scheiner M, Hedges LK, Butler MG and Schwartz HS: Microsatellite instability in malignant melanoma. Cancer Genet Cytogenet 104: 111-114, 1998.
36. Runger TM, Emmert S, Schadendorf D, Diem C, Epe B and Hellfritsch I: Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine or etoposide. J Invest Dermatol 114: 34-39, 2000.
37. Charbonnier N, Martin C, Scotte M, Silbert L, Moreau V and Frebourg T: Alternative splicing of MLH1 messenger RNA in human normal cells. Cancer Res 55: 1839-1841, 1995.
38. Clarke LA, Veiga I, Isidro G, Jordan P, Ramos JS, Castedo S and Boavida MG: Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation. Genes Chromosome Cancer 29: 367-370, 2000.
39. Tanko Q, Franklin B, Lynch H and Knezetic J: A hMLH1 genomic mutation and associated mRNA defects in a hereditary non-polyposis colorectal cancer family. Mutat Res 503: 37-42, 2002.
40. Eshleman JR and Markowitz D: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7: 83-89, 1995.